Literature DB >> 30665568

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Jürgen Floege1, Sean J Barbour2, Daniel C Cattran3, Jonathan J Hogan4, Patrick H Nachman5, Sydney C W Tang6, Jack F M Wetzels7, Michael Cheung8, David C Wheeler9, Wolfgang C Winkelmayer10, Brad H Rovin11.   

Abstract

The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline's publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IgA nephropathy; KDIGO; hypertension; kidney biopsy; membranous nephropathy; proteinuria

Mesh:

Year:  2019        PMID: 30665568     DOI: 10.1016/j.kint.2018.10.018

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  82 in total

1.  Proposal of classification of "chronic kidney disease (CKD) with diabetes" in clinical setting.

Authors:  Munehiro Kitada; Daisuke Koya
Journal:  Diabetol Int       Date:  2019-04-29

Review 2.  IgA Vasculitis in Adults: a Rare yet Challenging Disease.

Authors:  Kinanah Yaseen; Leal C Herlitz; Alexandra Villa-Forte
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

Review 3.  Lupus nephritis.

Authors:  Hans-Joachim Anders; Ramesh Saxena; Ming-Hui Zhao; Ioannis Parodis; Jane E Salmon; Chandra Mohan
Journal:  Nat Rev Dis Primers       Date:  2020-01-23       Impact factor: 52.329

4.  Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.

Authors:  Mark Canney; Sean J Barbour; Yuyan Zheng; Rosanna Coppo; Hong Zhang; Zhi-Hong Liu; Keiichi Matsuzaki; Yusuke Suzuki; Ritsuko Katafuchi; Heather N Reich; Daniel Cattran
Journal:  J Am Soc Nephrol       Date:  2020-12-23       Impact factor: 10.121

5.  Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy.

Authors:  Dohui Hwang; Kyoungjin Choi; Nam-Jun Cho; Samel Park; Byung Chul Yu; Hyo-Wook Gil; Eun Young Lee; Soo Jeong Choi; Moo Yong Park; Jin Kuk Kim; Seung Duk Hwang; Soon Hyo Kwon; Jin Seok Jeon; Hyunjin Noh; Dong Cheol Han; Hyoungnae Kim
Journal:  Nephrology (Carlton)       Date:  2021-03-03       Impact factor: 2.506

Review 6.  Treatment of IgA nephropathy in children: a land without KDIGO guidance.

Authors:  Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2020-02-14       Impact factor: 3.714

Review 7.  IgA Vasculitis and IgA Nephropathy: Same Disease?

Authors:  Evangeline Pillebout
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

8.  Serum Levels of miR-148b and Let-7b at Diagnosis May Have Important Impact in the Response to Treatment and Long-Term Outcome in IgA Nephropathy.

Authors:  Nikoleta M Kouri; Maria Stangou; George Lioulios; Zoi Mitsoglou; Grazia Serino; Samantha Chiurlia; Sharon Natasha Cox; Persia Stropou; Francesco P Schena; Aikaterini Papagianni
Journal:  J Clin Med       Date:  2021-05-05       Impact factor: 4.241

9.  Gene Expression as a Guide to the Development of Novel Therapies in Primary Glomerular Diseases.

Authors:  Panagiotis Garantziotis; Stavros A P Doumas; Ioannis Boletis; Eleni Frangou
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

Review 10.  IgA vasculitis.

Authors:  Evangéline Pillebout; Cord Sunderkötter
Journal:  Semin Immunopathol       Date:  2021-06-25       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.